Rchr

J-GLOBAL ID：200901023585616140 Update date: Mar. 01, 2024

KUMAGAI Megumi

クマガイメグミ | KUMAGAI Megumi

Affiliation and department：
Job title： Research Assistant
Research theme for competitive and other funds (14)：

2022 - 2025 睡眠リズム障害の新規治療法の開発:リズム同調に関与する新規分子を標的として
2023 - 2024 食事時間制限法(TRF)が膵島β細胞の増殖・分化・成熟に及ぼす影響と作用機序の解明
2021 - 2022 概日リズム同調に関与する新規分子機構の解明
2022 - 糖尿病を時間栄養学的にコントロールする!
2021 - 2022 体内時計は糖尿病や脂質異常症などの生活習慣病の発症とかかわっているか?概日リズムと生活習慣病との関係を分子レベルで探る

Show all

Papers (4)：

T. Okabe, M. Kumagai, Y. Nakajima, S. Shirotake, K. Kodaira, M. Oyama, M.Ueno, M. Ikeda. The effects of HIF1α/ARNT on the number of NIH3T3 cells. PLOS ONE. 2014
Yang F, Inoue I, Kumagai M, Takahashi S, Nakajima Y, Ikeda M. Real-time analysis of the circadian oscillation of the Rev-Erb beta promoter. J Atheroscler Thromb. 2013. 20. 2. 267-76-276
Seiichiro Takahashi, Ikuo Inoue, Yoshihiko Nakajima, Makoto Seo, Takanari Nakano, Fang Yang, Megumi Kumagai, Tsugikazu Komoda, Takuya Awata, Masaaki Ikeda, et al. A Promoter in the Novel Exon of hPPARγ Directs the Circadian Expression of PPARγ. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS. 2010. 17. 1. 73-83-83
Yang F, Nakajima Y, Kumagai M, Ohmiya Y, Ikeda M. The molecular mechanism regulating the autonomous circadian expression of Topoisomerase I in NIH3T3 cells. Biochem Biophys Res Commun. 2009. 380. 22-27

Lectures and oral presentations (58)：

Glucocorticoids and Circadian Rhythm Regulation.
(2023)
Cellular and molecular basis of chronotherapy for cancer
(FAOPS2019 2019)
膵島β細胞への新規遺伝子導入法によるNotchシグナルの機能解析
(第41回日本分子生物学会年会 2018)
Molecular basis of chronotherapy for cancer
(2018)
Molecular basis of chronotherapy in cancer chemotherapy
(第15回RCGMフロンティアシンポジウム 2017)

ｍore...

Association Membership(s) (4)：

日本分子生物学会 , Physiological Society of Japan , Japanese Society for Chronobiology , The Japanese Society for Neurochemistry

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM